Showing results (1831-1840 of 52,386) with videos related to
Sort By:
Pageof 5,239
Frontiers in Immunology|April 15, 2025
The protective effect of Chlorella vulgaris against diclofenac toxicity in Clarias gariepinus: haemato-immunological parameters and spleen histological features as outcome markersAhmed Gabr, Amr M Mohamed, Nasser S Abou Khalil, et al.Frontiers in Immunology|April 15, 2025
ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancerXiao-Rui Chen, Xue-Ying Tan, Zong-Liang Zhang, et al.Frontiers in Immunology|April 14, 2025
Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experienceSilvia Di Bari, Francesco Izzo, Livia Bresciani, et al.Frontiers in Immunology|April 14, 2025
The role of macrophages in hypertrophic scarring: molecular to therapeutic insightsLele Shen, Yao Zhou, Jie Gong, et al.Frontiers in Immunology|April 14, 2025
Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategiesXinqi Xu, Tingyu Yang, Jiapan An, et al.Frontiers in Immunology|April 14, 2025
Design of a peptide-based vaccine against human respiratory syncytial virus using a reverse vaccinology approach: evaluation of immunogenicity, antigenicity, allergenicity, and toxicityHadeel Alnajran, Maaweya Awadalla, Fahad M Aldakheel, et al.Frontiers in Immunology|April 14, 2025
Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapyHejing Bao, Jiani Zhang, Xi Luo, et al.Frontiers in Immunology|April 14, 2025
Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinomaTalita Aguiar, Shunya Mashiko, Kesava Asam, et al.Frontiers in Immunology|May 2, 2025
Regulatory T cell epitope content in human antibodies decreases during maturationAndres H Gutierrez, Frances E Terry, Amy S Rosenberg, et al.Frontiers in Immunology|May 2, 2025
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapyLingling Yin, Bin Lv, Jiao Ge, et al.Pageof 5,239